SCHEMBL7269185

SCHEMBL7269185

CCOC(=O)c1cn2ccc(CC)cc2n1

nearest known ligand 0.78

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.78
POLB P06746 1/20 0.78
GAA P10253 1/20 0.52
ALDH1A1 P00352 1/20 0.51
HPGD P15428 1/20 0.51
RAB9A P51151 6/20 0.48
MAPT P10636 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
GABRA2 P47869 7/20 0.47
GABRB2 P47870 7/20 0.47
CYP1A2 P05177 1/20 0.46
NPC1 O15118 4/20 0.45
RXFP1 Q9HBX9 1/20 0.45
KMT2A Q03164 1/20 0.44
PKM P14618 1/20 0.43
KLF5 Q13887 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15744771 0.92 KDM4E (0.74) KDM4EPOLBGAAALDH1A1HPGD
SCHEMBL20887367 0.91 KDM4E (0.72) KDM4EPOLBGAAALDH1A1HPGD
SCHEMBL20887271 0.87 KDM4E (0.67) KDM4EPOLBGAAALDH1A1HPGD
SCHEMBL1445451 0.87 KDM4E (1.00) KDM4EPOLBGAAALDH1A1HPGD
SCHEMBL17437886 0.86 KDM4E (0.78) KDM4EPOLBGAAALDH1A1HPGD
SCHEMBL8606874 0.85 KDM4E (0.65) KDM4EPOLBGAAALDH1A1HPGD
SCHEMBL15767159 0.85 KDM4E (0.76) KDM4EPOLBGAAALDH1A1HPGD
SCHEMBL1647902 0.85 KDM4E (0.76) KDM4EPOLBGAAALDH1A1HPGD
SCHEMBL975342 0.85 KDM4E (0.76) KDM4EPOLBGAAALDH1A1HPGD
SCHEMBL16691126 0.85 KDM4E (0.76) KDM4EPOLBGAAALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0370381-B1 2(1H)-quinolinone compounds, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1995-05-10 EP disclosed
US-4988698-A Cardiovascular disorders, hypotensive agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-01-29 US disclosed
EP-0370381-A2 2(1H)-quinolinone compounds, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-05-30 EP disclosed